• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET ORTHOPEDICS M2A-T UNIV 2-HOLE SHL SZ 41/52; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET ORTHOPEDICS M2A-T UNIV 2-HOLE SHL SZ 41/52; PROSTHESIS, HIP Back to Search Results
Model Number N/A
Device Problems Unstable (1667); Device Dislodged or Dislocated (2923)
Patient Problems Inflammation (1932); Pain (1994); Loss of Range of Motion (2032); Tissue Damage (2104); Toxicity (2333); Reaction (2414); Osteopenia/ Osteoporosis (2651); Limited Mobility Of The Implanted Joint (2671)
Event Date 06/21/2012
Event Type  Injury  
Event Description
Legal counsel for patient reported patient underwent a left total hip arthroplasty on (b)(6) 2002.Legal counsel reports patient allegations of pain, impairment, lack of mobility, inflammation, loss off range of motion, damage to surrounding bone and tissue and metallosis.Subsequently, patient was revised on (b)(6) 2012.Additional information provided in patient medical records indicates the left hip revision on (b)(6) 2012, was due to pain, instability, and dislocation.The patient¿s operative report noted cystic defect, synovial reaction, fibrous tissue, osteolytic lesions; and the acetabular component showed retroversion.This report is based on allegations set forth in plaintiff's complaint, and the allegations contained therein are unverified.
 
Manufacturer Narrative
Current information is insufficient to permit a conclusion as to the cause of the event.Review of device history records show that lot released with no recorded anomaly or deviation.There are warnings in the package insert that state that this type of event can occur: under possible adverse effects: 1.Material sensitivity reactions.4.Loosening or migration of the implants may occur due to loss of fixation, trauma, malalignment, bone resorption, excessive activity.6.Inadequate range of motion due to improper selection or positioning of components.8.Dislocation and subluxation due to inadequate fixation and improper positioning.This report is based on allegations set forth in plaintiff's complaint, and the allegations contained therein are unverified.This report is number 2 of 2 mdrs filed for the same event (reference 1825034-2014-04238 and 06393).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M2A-T UNIV 2-HOLE SHL SZ 41/52
Type of Device
PROSTHESIS, HIP
Manufacturer (Section D)
BIOMET ORTHOPEDICS
56 e. bell drive
warsaw IN 46582
Manufacturer (Section G)
BIOMET ORTHOPEDICS
56 e. bell drive
warsaw IN 46582
Manufacturer Contact
megan haas
56 e. bell drive
warsaw, IN 46582
5743726700
MDR Report Key3955128
MDR Text Key4627414
Report Number0001825034-2014-06393
Device Sequence Number1
Product Code KWY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK003363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Attorney
Type of Report Initial
Report Date 07/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/01/2012
Device Model NumberN/A
Device Catalogue Number15-103682
Device Lot Number121140
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/12/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/17/2002
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
-
-